Available Until 2/8/2025

Challenges in Cardiometabolic Care: Interprofessional Implementation of SGLT2 Inhibitors

ACPE Number: 0204-0000-23-414-H01-P
Content Release Date: February 8, 2024
Expiration Date: February 8, 2025
Activity Type: Application-based
CE Credits: 1.5 contact hours (0.15 CEUs)
Activity Fee:  Free

Activity Overview

Clinical trials and real-world analyses have consistently demonstrated the positive impact of SGLT2 inhibitors on cardiorenal outcomes in patients with type 2 diabetes (T2D), heart failure (HF), and chronic kidney disease (CKD). Based on these benefits, SGLT2 inhibitors have acquired a central role in the treatment of T2D, CKD, and HF. This educational activity will present the latest data from the landmark clinical trials examining the effects of SGLT2 inhibitors on cardiorenal outcomes, review updated clinical practice guidelines for heart failure, diabetes, and CKD, and describe care models that incorporate pharmacists into the initiation, titration, and monitoring of SGLT2 inhibitor therapy for patients who could benefit from treatment.

*Please note, this activity was presented live on December 4, 2023 as part of the ASHP 2023 Midyear Clinical Meeting & Exhibition. You can only claim credit once for this activity; live or home study

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

This activity was planned to meet the educational needs of pharmacists who practice in hospitals, health systems, community pharmacies, and ambulatory clinics who care for or are interested in the care of patients who have type 2 diabetes, heart failure, and/or chronic kidney disease. 

After participating in this CPE activity, learners should be able to:

  • Evaluate the benefits and risks of SGLT2 inhibitors in people with type 2 diabetes (T2D), heart failure (HF), and/or chronic kidney disease (CKD).
  • Construct a treatment plan to reduce cardiorenal risk in people with T2D, HF, and/or CKD according to evidence-based guidelines and patient-specific factors.
  • Describe models for collaborative management of people with type 2 diabetes, HF, and/or CKD.

Leo F. Buckley, PharmD, MPH, BCCP
Clinical Pharmacy Specialist
Brigham and Women’s Hospital
Boston, Massachusetts



Leo F. Buckley, PharmD, MPH, BCCP is a clinical pharmacy specialist in the Department of Pharmacy at Brigham and Women's Hospital in Boston, Massachusetts. He graduated from Northeastern University's School of Pharmacy and completed residencies in Pharmacy Practice and Cardiovascular Pharmacotherapy at Brigham and Women's Hospital. After a research fellowship at Virginia Commonwealth University, he returned to Brigham and Women's where he leads a cardiovascular pharmacology research program and practices as a clinical pharmacist. His clinical and research interests include cardio-renal inflammation and metabolism.

 

Susan Cornell, PharmD, CDCES, FAPhA, FADCES
Associate Director of Experiential Education
Professor in Pharmacy Practice – Midwestern University College of Pharmacy
Downers Grove, IL

Diabetes Care & Education Specialist – Bolingbrook Christian Health Center
Bolingbrook, Illinois



Susan Cornell, PharmD, CDCES, FAPhA, FADCES is the associate director of experiential education and professor in the department of pharmacy practice at Midwestern University College of Pharmacy in Downers Grove, Illinois. Dr. Cornell is also a clinical pharmacist and certified diabetes care and education specialist with the Bolingbrook Christian Health Center, where she trains, educates, and supervises students from the colleges of medicine, pharmacy, and health sciences, as they provide medication therapy management and diabetes care and education for underserved populations. Dr. Cornell served as president of the Illinois Pharmacists Association in 2011. She has received numerous awards and recognitions, including the 2022 Allene Von Son Distinguished Service Award, the 2021, 2019 and 2011 Outstanding Faculty Advisor, 2017 Outstanding Illinois Diabetes Educator of the Year, 2014 Bowl of Hygeia, to list a few. She is an active member of the American Diabetes Association. She is also actively involved with the Association of Diabetes Care and Education Specialists, where she served on their board of directors from 2004 to 2007 and continues to assist on various committees. Dr. Cornell has been invited to give numerous presentations to various healthcare professionals and community groups worldwide. She has served as editor, as well as, published and contributed to many peer-reviewed, professional written and online publications. Dr. Cornell served as an associate editor of the ADCES Art and Science of Diabetes Care and Education Desk Reference- 3rd thru 6th edition.


Jeffery S. Vender, MD, MCCM, MBA is the Emeritus, Harris Family Foundation Chairman of the Department of Anesthesiology at NorthShore University Health System in Evanston, Illinois and a Clinical Professor at the University of Chicago Pritzker School Of Medicine in Chicago, Illinois. He is a past member of the NorthShore University Health System Faculty Practice Associates Board of Directors, Past Chair of the Medical Executive Committee for the Professional Staff at NorthShore and previously served on Northshore’s Board of Directors. Dr. Vender served as Chair of Anesthesia from 1990-2015 and received an appointment of adjunct Professor of Biomedical Engineering at Northwestern University. He served as the Director of the Critical Care Services at Evanston Hospital from 1987-2000 and the Interim Chairman at Northwestern University Department of Anesthesiology from July 1999 until October 2000. Dr. Vender has participated and Chaired numerous state and national committees of various medical organizations, edited several medical texts, has published over 135 articles and book chapters and has been an invited lecturer at over 250 national and international meetings on topics of anesthesiology, critical care, organizational change, and leadership. In addition, Dr. Vender serves as an editor and/or reviewer for many medical journals.
 

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.

The following persons in control of this activity’s content have relevant financial relationships:

  •          Leo F. Buckley: Kiniksa Pharmaceuticals – Consultant
  •          Susan Cornell: Novo Nordisk, Inc. – Advisory Board

As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity.

Claim CE Within 60 Days

To receive CE credit, complete the steps below within 60 days of completing the activity.

  1.        View the entire presentation and answer all polling questions.
  2.        Click "Complete Activity" on last slide then complete the evaluation to claim credit. 
  3.        Verify credits were successfully transferred to CPE Monitor before the ACPE 60-day deadline by checking your NABP eProfile account.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned – no exceptions! To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, we encourage you to check your NABP eProfile account to validate your credits were transferred successfully before the ACPE 60-day deadline. After the 60 day deadline, ASHP will no longer be able to award credit for this activity.

Provided by ASHP

Supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.